Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

61) $141,030 $(445,005)

Diluted earnings (loss) per

share $0.34 $(4.80) $1.27 $(4.37)

Diluted weighted average

shares outstanding 117,374 101,892 117,039 101,761

The following table presents Watson's Condensed Consolidated Balance Sheets as of December 31, 2007 and 2006:

Table 2

Watson Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(Unaudited; in thousands)

December 31, December 31,

2007 2006

Assets

Cash and cash equivalents $204,554 $154,171

Marketable securities 11,799 6,649

Accounts receivable, net 267,117 384,692

Inventories 490,601 517,236

Other current assets 199,705 198,928

Property and equipment, net 688,185 697,415

Investments and other assets 118,401 131,725

Product rights and other

intangibles, net 603,697 779,284

Goodwill 876,449 890,477

Total Assets $3,460,508 $3,760,577

Liabilities & Stockholders' Equity

Current liabilities $444,927 $689,929

Long-term debt 899,408 1,124,145

Deferred income taxes and other

liabilities 266,708 266,115

Stockholders' equity 1,
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 05, 2015 RURO, Inc., a leading ... version 7, the latest major content upgrade to its ... Upgrade is a significant advancement of FreezerPro® ... enhancing users experience, while also simplifying , ... requirements , Download available immediately for free ...
(Date:5/5/2015)... , May 5, 2015  Blueprint Medicines ... of its initial public offering of 9,367,708 shares ... of $18.00 per share, including shares of common ... underwriters of their option to purchase additional shares. ... to Blueprint Medicines were approximately $168.6 million, before underwriting ...
(Date:5/5/2015)... DIEGO AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences ... today reported financial results for the three months ended ... specified otherwise, all amounts are in Canadian dollars. ... its fiscal year end from May 31 to December ... interim period being reported is for the three months ...
(Date:5/5/2015)... Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... the detection of foodborne pathogens,  today announced that Paul ... Merrill Lynch 2015 Health Care Conference on May 12 at ... the Wynn, Las Vegas NV. ... available through the investor relations section of Roka Bioscience,s website ...
Breaking Biology Technology:RURO Releases version 7 of FreezerPro® software 2Blueprint Medicines Announces Closing of Initial Public Offering 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8
... SolvayCARES Thriving Student ... -, MARIETTA, Ga., Sept. 15 Solvay Pharmaceuticals, ... with,cystic fibrosis (CF) through its SolvayCARES Scholarship program. Each,student ... finance,post-secondary education. This fall, one SolvayCARES Scholarship winner,will go ...
... Modigene Inc.,(OTC Bulletin Board: MODG), a biopharmaceutical ... of already approved,therapeutic proteins, today announced that President ... Life Sciences Conference at 2:00 PM EDT,on September ... company,s presentation will be webcast live.,It can be ...
... QC, Sept. 15 /PRNewswire-FirstCall/ - Neptune Technologies ... today,that its distributor Schiff Nutrition International Inc. ... (NKO(R)) in Walgreens,which represents the largest retail ... 6,400 drug stores nationwide. Schiff(R) MegaRed(TM) has ...
Cached Biology Technology:40 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 240 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 340 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 4Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 2Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 3
(Date:3/24/2015)... GARDENS, Fla. , March 24, 2015 /PRNewswire/ ... identity management solutions, today announced that its U.are.U ... clothing accessory retailer Goorin Bros . to ... Crossmatch biometrics-based solution secures access to the POS ... the increased risk of data breaches. ...
(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... parasite may trigger the development of schizophrenia and other ... Leeds, Faculty of Biological Sciences (UK) has shown that ... of these disorders by affecting the production of dopamine ... controlling aspects of movement, cognition and behaviour. Toxoplasmosis, ...
... (March 10, 2009) -- Virginia Commonwealth University Life Sciences ... uses to enter human red blood cells, which could ... fight the mosquito-borne disease. Malaria is transmitted to ... for Disease Control and Prevention, between 350 million and ...
... by Professor Donny Strosberg of Scripps Florida, was published on ... ,s advance, online edition, Papers in Press. In ... of two or more amino acids) derived from the core ... inhibit not only dimerization of the core protein (the joining ...
Cached Biology News:Research supports toxoplasmosis link to schizophrenia 2Researchers identify new way the malaria parasite and red blood cells interact 2Scripps research team identifies key molecules that inhibit viral production 2Scripps research team identifies key molecules that inhibit viral production 3
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Biology Products: